CVS Health reported third-quarter earnings that showcased a revenue of $95.43 billion, surpassing analyst expectations of $92.75 billion. This represents a year-over-year increase of 6.31%. However, the company fell short on earnings per share (EPS), posting $1.09, which is a 50.68% decline from the previous year and missed estimates by $0.44. The disappointing profit figures were attributed to a significant $1.1 billion reserve charge. Following a tumultuous year that has seen its shares decline, CVS Health has also initiated leadership changes under new CEO David Joyner.